PROVIDER PROFILE · NPI 1144310020

Michelle Mccall

NeuropsychiatryHelena, MTI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

125

Beneficiaries

—

Total drug cost

$3K

Distinct drugs

Brand share

16.8%

Top prescribed drugs

Clonazepam30 claims

Metformin Hcl21 claims

Atorvastatin Calcium17 claims

Lorazepam16 claims

Levothyroxine Sodium15 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Michelle Mccall's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 4 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Jean Justad Internal Medicine · Helena, MT	20	70
LABORATORY CORPORATION OF AMERICA	14	28

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Jean Justad Internal Medicine · Helena, MT	21	65
LABORATORY CORPORATION OF AMERICA	18	48
Laboratory Corporation Of America Clinical Laboratory · Phoenix, AZ	16	36
Craig Wilkerson Ophthalmology · Helena, MT	11	11

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history